Tuesday, August 12, 2014 2:23:16 PM
DBMM paid for promotions on 9/12/13 to the owners (Promoters) of 9 newsletter. Paid promotion again 12/2/13 on 8 newsletters.If by chance you've been a bag holder since near any of those dates, you'll recall how the stock accelerated in price, then tanked.
I bring this up as a history lesson. Usually when a stock is nearing a pump you'll see the price drop substantially (we're at .0001) and all that is seen on my level 2 is red sales... no-one is buying; and why should we? This stock is tanking - Right?
Next month will be one year since the anniversary of the last pump. It has been my experience, of the past 5 plus years, history of this kind tends to repeat. On the negative side, the regulators are hot on the tails of bad promotions, on the positive side is the history.
No-one is saying this won't completely tank, go banko and you loose all your invested dollars. With that disclaimer, if you buy now at .0001 ($100.00 per million shares) and you spend $1,000.00 every tick this stock goes up during a promotion will give you back $1000.00!
I'm a bag holder as well, so I have just as much to lose as many of you. I'm in with 10,000,000 shares at .0002. I'm one that is hoping (hopium) for history to repeat and pay me for the wait. We'll see if history is reliable indicator in the next few months.
Tip for surviving a promotion... Be sure to sell your shares as the stock is going up. Best to sell a small amount at a time and not pre-load the ask side by setting up GTC (good til cancelled) orders ahead of time. Why? Buyers will see the high amount of shares that have to be bought before the stock can go up and will treat this as resistance and will wait to see if others are buying before they commit.
We need a promo!
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM